Conference Keynote: White Privilege and the Biopolitics of Race
Genomics has resurrected scientific interest in biological concepts of race by attempting to identify race at the molecular level. In that last decade, there has been an explosion of biotechnologies that use race as a biological category, such as race-specific pharmaceuticals, commercial genetic testing for determining racial identity and genealogy, egg donation and embryo selection involving race, and racial profiling with DNA forensics. These technological innovations are part of a new biopolitics of race that helps to maintain white privilege in the 21st century, post-civil rights era. We must contest both the persistent myth that race is natural and persistent injustices based on race.
10th Annual White Privilege Conference Keynote Address
Saturday, April 4, 2009
To purchase a DVD of this speech, please contact the WPC office at 719-255-4764.
This journal is an academic publication. Its sole purpose is the dissemination of knowledge to as wide an audience as possible. The journal is free to individuals and institutions.
Copyrights for contributions published in this journal are retained by the authors, with first publication rights granted to the journal.
Copies of this journal or articles in this journal may be distributed for research or educational purposes free of charge and without permission. However commercial use of the journal or the articles contained herein is expressly prohibited without the written consent of the author.
NOTE TO AUTHORS:
A new model, the Creative Commons approach, with split copyright is rapidly evolving and worth considering.